BELLEVUE GROUP AG Viridian Therapeutics, Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$946,000
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

+77.27%
quarter

Viridian Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -5.92% -2.9K shares 379K $20.51 46.1K
Q2 2022 share Increase 0.00% 49K shares 567K $11.57 49K